Chemistry:Felcisetrag

From HandWiki

Felcisetrag (TAK-954, TD-8954) is a drug which acts as a potent and highly selective agonist for the serotonin receptor 5-HT4. It is in clinical trials for the treatment of gastroparesis.[1][2][3][4]

References

  1. "Randomised study: effects of the 5-HT4 receptor agonist felcisetrag vs placebo on gut transit in patients with gastroparesis". Alimentary Pharmacology & Therapeutics 53 (9): 1010–1020. May 2021. doi:10.1111/apt.16304. PMID 33711180. 
  2. "Clinical and Nonclinical Disposition and In Vitro Drug-Drug Interaction Potential of Felcisetrag, a Highly Selective and Potent 5-HT4 Receptor Agonist". European Journal of Drug Metabolism and Pharmacokinetics 47 (3): 371–386. May 2022. doi:10.1007/s13318-021-00751-8. PMID 35157234. 
  3. "Safety and Efficacy of Highly Selective 5-Hydroxytryptamine Receptor 4 Agonists for Diabetic and Idiopathic Gastroparesis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials". Cureus 16 (1). January 2024. doi:10.7759/cureus.51851. PMID 38327939. 
  4. "A randomized phase 2 study of the 5-HT4 receptor agonist felcisetrag for postoperative gastrointestinal dysfunction after bowel surgery". American Journal of Surgery 234: 162–171. August 2024. doi:10.1016/j.amjsurg.2024.04.030. PMID 38724293.